Contributing Member of the Healthcare Councils

Names and details of certain GLG News authors are available only to GLG Clients and Council Members. GLG News authors are subject-matter experts within the GLG Councils and are available for expert consulting - by phone, in-person, or written analysis. To find out how to become a GLG client or Council Member, click here.

GLG News by this Author

Analyses are solely the work of the authors and have not been edited or endorsed by GLG.

GLG News is now G+ Insights

G+ is a community for professionals, academics and entrepreneurs to connect through online discussions and in-person meetings. You will continue to see G+ Insights (formerly GLG News) here as well as on the G+ website, where you can share and discuss the G+ Insights you read.

New Direction for an Ongoing Problem

July 14, 2009

Bayer seeks US FDA approval for estradiol-based oral contraceptive to treat heavy menstrual bleeding | www.pharmabiz.com

The announcement by Bayer of submission of a novel estradiol based oral contraceptive to treat heavy menstrual bleeding addresses a growing trend among medical device makers and pharmaceutical companies: how to become involved in the growing market for medical and surgical treatments of heavy menstrual bleeding in order to lower the rate of hysterectomies performed for this reason.

EMR Debate

June 9, 2009

Electronic Patient Records will Force Consolidation in Health Care | bits.blogs.nytimes.com

This article summarizes two key points-- one in the world of business and another in the world of medicine -- about the EMR debate. One is how corporations view this opportunity and the other is about the relationship between physicians and hospitals.

Page : 11 to 2 of 2

Subscribe to Updates

RSS By RSS

Add to Google Reader or Homepage

Subscribe in Bloglines

This author consults with leading institutions through GLG